Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2026)

Vir Biotechnology has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $170.6 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 43.48% year-over-year to $170.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 26.09% YoY) and the FY2025 annual result came in at $1.2 billion, down 30.91% from the prior year.
• Change in Acquisitions & Divestments retreated to $170.6 million in Q1 2026 per VIR's latest filing, from $342.9 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $715.7 million in Q4 2023 and troughed at $84.8 million in Q3 2022.
• A 5-year average of $377.6 million and a median of $342.9 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments surged 427.69% in 2023, then slumped 57.93% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $266.7 million in 2022, then soared by 168.39% to $715.7 million in 2023, then tumbled by 57.93% to $301.1 million in 2024, then grew by 13.88% to $342.9 million in 2025, then plunged by 50.25% to $170.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $170.6 million, $342.9 million, and $305.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.